Mark Zuckerberg-Backed AI Startup Takes Over Parkinson’s Treatment From the Maker of Ozempic

Gizmodo
Read full post
A startup supported by Mark Zuckerberg has acquired the company that developed Ozempic to advance Parkinson's disease treatment. This move aims to innovate therapies for Parkinson's by leveraging AI technologies.

More in Healthcare

UK Is Urged to Overhaul Regulation of AI-Medical Devices

Covered by 2 sources
Healthcare6 min read

NYU-DRP AI Model Predicts Five-Year Breast Cancer Risk From 3D Mammograms

Unite.AI
Healthcare3 min read

Google’s map of every possible DNA typo could speed up rare disease research

Covered by 3 sources